Taprostene他前列烯,108945-35-3

价格询价

品牌MedChemExpress(MCE)
产地美国
货号HY-114671
更新日期2025年12月05日

MedChemExpress LLC

品牌商

14 年钻石会员

Taprostene

CAS No. : 108945-35-3

MCE 国际站：Taprostene

产品活性：Taprostene (CG-4203) 是一种合成的、化学稳定的前列环素 (PGI2) 类似物。Taprostene 在猫急性心肌缺血再灌注后表现出内皮和心肌保护作用。Taprostene 增强细胞保护作用，同时最大限度地减少不必要的血液动力学影响。

研究领域：GPCR/G Protein

作用靶点：Prostaglandin Receptor

In Vivo: Taprostene (100 ng/kg/min) is infused intravenously starting 30 minutes postocclusion of the left anterior descending coronary artery followed by reperfusion 1 hour later in a 6-hour model of myocardial ischemia (MI) with reperfusion in anesthetized cats. Taprostene infusion results in significantly lower plasma creatine phosphokinase activities for the MI + Taprostene group compared with the MI + vehicle group.Taprostene has a profile of activity including prevention of aggregation in cat platelets15 at concentrations that are much lower than that required to produce significant vasodilator activity in rabbit aortic rings. In addition to antiaggregatory and cytoprotective effects in circulatory shock, Taprostene exerts beneficial effects in acute inflammatory states and in rat models of myocardial hypoxia and permanent ischemia.A variety of infusion rates of Taprostene from 50 to 200 ng/kg/min were initially used to obtain an infusion rate that produced minimal hemodynamic (i.e., vasodilator) effects but still exerted cardioprotective effects. Taprostene treatment inhibits neutrophils adhering to the myocardial endothelium in both jeopardized and necrotic myocardial tissue after ischemia and reperfusion.